English | 繁體

Search in the results

UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Cost-utility analysis of newborn hepatitis B immunization in Beijing Journal article
Guo, Yiwei, Yang, Yong, Bai, Qian, Huang, Zhengwei, Wang, Zongwu, Cai, Dongxia, Li, Shuo, Man, Xiaowei, Shi, Xuefeng. Cost-utility analysis of newborn hepatitis B immunization in Beijing[J]. Human Vaccines and Immunotherapeutics, 2020, 17(4), 1196-1204.
Authors:  Guo, Yiwei;  Yang, Yong;  Bai, Qian;  Huang, Zhengwei;  Wang, Zongwu; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:4.1/4.2 | Submit date：2022/05/13
Beijing  Cost-utility  Economic Evaluation  Hepatitis b  Vaccination  
Research and development of mAb drugs in China: a look from policy perspectives Journal article
Rong Jiang, Yuanyuan Sun, Carolina Ung, Xinyue Dong, Xiangjun Kong, Yuanjia Hu, Rong Shao. Research and development of mAb drugs in China: a look from policy perspectives[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15(11), 2695-2705.
Authors:  Rong Jiang;  Yuanyuan Sun;  Carolina Ung;  Xinyue Dong;  Xiangjun Kong; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:4.1/4.2 | Submit date：2020/03/12
r&d Support And Guidance Policy  Clinical Trial Policy  Drug Lag  Innovation Support System  Mab Drugs  Marketing Approval Policy  
Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980-2016) Journal article
Yunfeng Lai, Sizhuo Suo, Ruibing Wang, Xiangjun Kong, Yuanjia Hu, Daisheng Tang, Honghao Shi, Shengqi Chen, Hao Hu. Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980-2016)[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14(4), 847-855.
Authors:  Yunfeng Lai;  Sizhuo Suo;  Ruibing Wang;  Xiangjun Kong;  Yuanjia Hu; et al.
Favorite | TC[WOS]:8 TC[Scopus]:11  IF:4.1/4.2 | Submit date：2020/04/06
Technology Commercialization  Citespace  Ims  Mab  Monoclonal Antibody  
Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980–2016) Journal article
Lai,Yunfeng, Wang,Ruibing, Chen,Xin, Tang,Daisheng, Hu,Yuanjia, Cai,Jing, Zhang,Qingwen, Hu,Hao. Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980–2016)[J]. Human Vaccines and Immunotherapeutics, 2017, 13(6), 1388-1397.
Authors:  Lai,Yunfeng;  Wang,Ruibing;  Chen,Xin;  Tang,Daisheng;  Hu,Yuanjia; et al.
Favorite | TC[WOS]:16 TC[Scopus]:22  IF:4.1/4.2 | Submit date：2021/03/01
Citespace  Intellectual Landscape  Mab  Monoclonal Antibody  Scientometric  
Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980-2016) Journal article
Lai, Yunfeng, Wang, Ruibing, Chen, Xin, Tang, Daisheng, Hu, Yuanjia, Cai, Jing, Zhang, Qingwen, Hu, Hao. Emerging trends and new developments in monoclonal antibodies: A scientometric analysis (1980-2016)[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13(6), 1388-1397.
Authors:  Lai, Yunfeng;  Wang, Ruibing;  Chen, Xin;  Tang, Daisheng;  Hu, Yuanjia; et al.
Favorite | TC[WOS]:16 TC[Scopus]:22  IF:4.1/4.2 | Submit date：2018/10/30
Citespace  Intellectual Landscape  Monoclonal Antibody  Mab  Scientometric  
Research and development of therapeutic mAbs: An analysis based on pipeline projects Journal article
Geng X., Kong X., Hu H., Chen J., Yang F., Liang H., Chen X., Hu Y.. Research and development of therapeutic mAbs: An analysis based on pipeline projects[J]. Human Vaccines and Immunotherapeutics, 2015, 11(12), 2769-2776.
Authors:  Geng X.;  Kong X.;  Hu H.;  Chen J.;  Yang F.; et al.
Favorite | TC[WOS]:26 TC[Scopus]:31 | Submit date：2018/11/06
Development Trends  Monoclonal Antibody  Patent Citation Network  Pipeline Projects  r&d  Therapeutic Application  
Dendritic-cell-based technology landscape: Insights from patents and citation networks Journal article
Kong X., Hu Y., Cai Z., Yang F., Zhang Q.. Dendritic-cell-based technology landscape: Insights from patents and citation networks[J]. Human Vaccines and Immunotherapeutics, 2015, 11(3), 682-688.
Authors:  Kong X.;  Hu Y.;  Cai Z.;  Yang F.;  Zhang Q.
Favorite | TC[WOS]:8 TC[Scopus]:9 | Submit date：2018/12/28
Citation Network  Dendritic Cells  Immunotherapy  Patent Landscape  Patent Ownership  Patenting Strategy  Technology Development  
Dendritic-cell-based technology landscape: Insights from patents and citation networks Journal article
Kong,Xiangjun, Hu,Yuanjia, Cai,Zhifang, Yang,Fengqing, Zhang,Qianru. Dendritic-cell-based technology landscape: Insights from patents and citation networks[J]. Human Vaccines and Immunotherapeutics, 2015, 11(3), 682-688.
Authors:  Kong,Xiangjun;  Hu,Yuanjia;  Cai,Zhifang;  Yang,Fengqing;  Zhang,Qianru
Favorite | TC[WOS]:8 TC[Scopus]:9  IF:4.1/4.2 | Submit date：2021/03/01
Citation Network  Dendritic Cells  Immunotherapy  Patent Landscape  Patent Ownership  Patenting Strategy  Technology Development